Surrozen (SRZN)

Technical Analysis Historical Data Financials News & Analysis

SRZN NEWS

HC Wainwright Reiterates “Buy” Rating for Surrozen (NASDAQ:SRZN) By MarketBeat - 3 weeks ago

Surrozen (NASDAQ:SRZN – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They presently have a $32.00 target p… [+3255 chars]...

Read more
Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway By Site Author - 3 weeks ago

Newly granted patent is part of the expanding intellectual property portfolio directed to: -generating novel and selective Wnt surrogate molecules with potentially broad therapeutic utility and -in… [+9220 chars]...

Read more
Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update By Site Author - 3 weeks ago

SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (Surrozen or the Company) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modula… [+18545 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		209.02 -2.96
-1.4%
CVX 		136.9 -0.47
-0.34%
CAT 		348.96 -0.37
-0.11%
INTC 		19.99 -0.26
-1.28%
MSFT 		467.68 3.81
0.82%
DIS 		112.53 -0.96
-0.85%
DOW 		28.18 -0.1
-0.35%
CSCO 		64.62 0.23
0.36%
GS 		605.88 6.67
1.11%